DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ugur O, Kothari PJ, Finn RD. et al.
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.
Nucl Med Biol 2002;
29 (02) 147-157
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.